Physician profile

Siva Sripada

Interventional Pain Medicine · Flint, MI

NPI 1174586267

$10,245.92

in general payments reported to CMS, 2019-2025

34 companies · $4,486 in 2025

The $4,486 reported for 2025 was more than what 90% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,005.80
Travel and Lodging$2,030.10

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Saluda Medical Americas, INC. $2,177.35 2025 Evoke
Boston Scientific Corporation $1,316.08 2019-2025 General - Pain Management, Intracept, Intracept Rf Probe
Medtronic, INC. $1,250.24 2024 Synchromedii
Horizon Therapeutics Plc $987.43 2019-2022
Globus Medical, INC. $768.82 2025 Senza, Vyrsa V1
Nalu Medical, INC. $697.45 2021-2025 Nalu Neurostimulation System
Nevro Corp. $620.65 2021-2024 Senza
Abbvie INC. $324.99 2022-2025
Abbott Laboratories $297.44 2019-2023 Proclaim
Stryker Corporation $251.02 2022-2025 Mild Device Kit
Averitas Pharma INC. $212.36 2023-2025 Qutenza
Spr Therapeutics, INC $160.19 2025 Sprint Pns System
Vertos Medical, INC. $153.81 2024 Mild Device Kit
Spinal Simplicity, LLC $142.57 2025 Ha Minuteman G3-R
Mml US, INC. $134.80 2022
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $123.50 2024 Wegovy
Curonix LLC $122.59 2024 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Neurelis, INC. $97.95 2024-2025 Valtoco
Brixton Biosciences, INC. $47.91 2024 Neural Ice
Biodelivery Sciences International, INC. $46.75 2019-2021
Takeda Pharmaceuticals U.S.A., INC. $32.41 2024 Cuvitru
Octapharma USA, INC. $28.53 2024 Panzyga
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $26.40 2021
Pfizer INC. $26.13 2020
Emd Serono, INC. $25.32 2025
Tanabe Pharma America, INC. $24.85 2024
Ucb, INC. $23.15 2025 Nayzilam
Painteq LLC $23.14 2024 Painteq
Relievant Medsystems, INC. $21.86 2020
Valinor Pharma, LLC $20.91 2025 Movantik
Bioventus LLC $16.19 2019
Si-Bone, INC. $15.92 2020
Biohaven Pharmaceutical Holding Company LTD. $15.33 2022
Hydrocision, INC. $11.88 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Siva Sripada

$10,245.92

in general payments reported 2019-2025

Years
2019-2025
Top company
Saluda Medical Americas, INC.
Context
The $4,486 reported for 2025 was more than what 90% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

https://glasscript.com/doctor/189551/siva-sripada

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.